Sponsor:
M.D. Anderson Cancer Center
Code:
NCT05126810
Conditions
Li-Fraumeni Syndrome
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
Questionnaire Administration
Brief summary:
Conditions
Li-Fraumeni Syndrome
Study ID
NCT05126810
Start date
Nov 3, 2022
Status verified date
Apr, 2026
Completion date
Oct 2, 2027
Anticipated
Primary completion date
Feb 2, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
500 participants
Anticipated
Arms
Observational (questionnaire)
Interventions
Questionnaire Administration
Primary outcome measure
Central contacts
Locations
M D Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Contacts
Principal Investigator:
Banu Arun
Sponsor
M.D. Anderson Cancer Center
Last update posted
Apr 15, 2026
Last verified
Apr, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-04-15.